GenPAx
Genpax develops a cloud-based, reference‑free whole‑genome sequencing analysis platform for bacterial pathogen surveillance. The company provides automated, scalable genomic analysis pipelines intended for infection prevention and control, public‑health surveillance, One Health applications and collaborative research, with an emphasis on high-resolution strain discrimination, antimicrobial-resistance gene detection, rapid turnaround, and cross-site comparability.
Industries
Nr. of Employees
small (1-50)
Products
Connectable whole‑genome sequencing analysis platform (cloud‑deployed, reference‑free)
A platform that performs reference‑free whole‑genome comparisons, provides SNP-level strain discrimination, detects AMR genes, enforces automated QC, and returns comparable results across laboratories via a secure web portal.
Connectable whole‑genome sequencing analysis platform (cloud‑deployed, reference‑free)
A platform that performs reference‑free whole‑genome comparisons, provides SNP-level strain discrimination, detects AMR genes, enforces automated QC, and returns comparable results across laboratories via a secure web portal.
Services
Turnkey service that accepts bacterial WGS FASTQ files via the cloud and returns high-resolution genomic analyses for surveillance, outbreak investigation, and AMR gene detection; designed to be usable without local bioinformatics expertise.
Short-term placements for clinical scientists to conduct WGS research projects (3–6 months) using the platform’s analysis capabilities; aimed at studies of healthcare-associated pathogens.
Turnkey service that accepts bacterial WGS FASTQ files via the cloud and returns high-resolution genomic analyses for surveillance, outbreak investigation, and AMR gene detection; designed to be usable without local bioinformatics expertise.
Short-term placements for clinical scientists to conduct WGS research projects (3–6 months) using the platform’s analysis capabilities; aimed at studies of healthcare-associated pathogens.
Expertise Areas
- Pathogen genomics and genomic epidemiology
- Antimicrobial-resistance (AMR) surveillance
- Public-health genomic surveillance and outbreak detection
- One Health and food‑chain pathogen surveillance
Key Technologies
- Whole‑genome sequencing (WGS)
- Reference‑free SNP and genome comparison algorithms
- Cloud‑based analytics and private cloud deployment
- Automated FASTQ-to-result pipelines
News & Updates
Genpax presented and participated at ASM Microbe 2024 (Atlanta).
Webinar on infection prevention and control listed on the events page.
Announcement of a strategic partnership to accelerate genomics and data analytics solutions for antimicrobial resistance and infectious diseases.
Publication and modelling estimating cost savings and health benefits of implementing WGS surveillance for healthcare‑associated infections in England and the USA.
Announcement that Genpax was named a winner of the IET Excellence and Innovation Award for Health Technology in 2023.
Winner of the IET Excellence and Innovation Award in the Health Technology category.
Genpax presented and participated at ASM Microbe 2024 (Atlanta).
Webinar on infection prevention and control listed on the events page.
Announcement of a strategic partnership to accelerate genomics and data analytics solutions for antimicrobial resistance and infectious diseases.
Publication and modelling estimating cost savings and health benefits of implementing WGS surveillance for healthcare‑associated infections in England and the USA.
Announcement that Genpax was named a winner of the IET Excellence and Innovation Award for Health Technology in 2023.
Winner of the IET Excellence and Innovation Award in the Health Technology category.